Journal article
Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine
Abstract
OBJECTIVES: To compare dosing convenience and adherence with abacavir (ABC) 300 mg plus a fixed-dose lamivudine 150 mg/zidovudine 300 mg combination tablet (COM) twice daily versus indinavir (IDV) plus COM twice daily in treatment-naïve, HIV-1-infected adults; and to evaluate the association among difficulty taking antiretroviral regimens, adherence, and virologic efficacy.
METHODS: An open-label, randomized, multicenter, international study …
Authors
Cahn P; Vibhagool A; Schechter M; Soto-Ramirez L; Carosi G; Smaill F; Jordan JC; Pharo CE; Thomas NE; Steel HM
Journal
Current Medical Research and Opinion, Vol. 20, No. 7, pp. 1115–1123
Publisher
Taylor & Francis
Publication Date
7 2004
DOI
10.1185/030079904125004051
ISSN
0300-7995